Grifols SA (GRFS)
6.57
+0.18
(+2.82%)
USD |
NASDAQ |
May 03, 16:00
6.575
0.00 (0.00%)
After-Hours: 20:00
Grifols 1 Year Total Returns (Daily): -8.88% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -8.88% |
May 02, 2024 | -13.53% |
May 01, 2024 | -10.19% |
April 30, 2024 | -13.81% |
April 29, 2024 | -13.14% |
April 26, 2024 | -11.39% |
April 25, 2024 | -13.04% |
April 24, 2024 | -14.80% |
April 23, 2024 | -14.40% |
April 22, 2024 | -16.78% |
April 19, 2024 | -16.49% |
April 18, 2024 | -13.15% |
April 17, 2024 | -13.53% |
April 16, 2024 | -9.96% |
April 15, 2024 | -13.15% |
April 12, 2024 | -12.30% |
April 11, 2024 | -11.10% |
April 10, 2024 | -5.17% |
April 09, 2024 | -4.39% |
April 08, 2024 | -2.93% |
April 05, 2024 | -0.70% |
April 04, 2024 | -4.32% |
April 03, 2024 | -4.17% |
April 02, 2024 | -8.01% |
April 01, 2024 | -9.36% |
Date | Value |
---|---|
March 28, 2024 | -5.38% |
March 27, 2024 | -5.67% |
March 26, 2024 | -5.40% |
March 25, 2024 | -7.15% |
March 22, 2024 | -6.47% |
March 21, 2024 | -1.02% |
March 20, 2024 | -5.56% |
March 19, 2024 | -9.69% |
March 18, 2024 | -9.84% |
March 15, 2024 | -17.72% |
March 14, 2024 | -25.39% |
March 13, 2024 | -17.02% |
March 12, 2024 | -17.56% |
March 11, 2024 | -11.27% |
March 08, 2024 | -10.14% |
March 07, 2024 | -29.70% |
March 06, 2024 | -33.78% |
March 05, 2024 | -27.84% |
March 04, 2024 | -22.46% |
March 01, 2024 | -20.76% |
February 29, 2024 | -13.28% |
February 28, 2024 | 7.85% |
February 27, 2024 | 1.20% |
February 26, 2024 | 3.22% |
February 23, 2024 | -1.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-60.12%
Minimum
Sep 29 2022
53.61%
Maximum
Sep 29 2023
-12.05%
Average
-14.41%
Median
Jan 24 2024
1 Year Total Returns (Daily) Benchmarks
DBV Technologies SA | -57.25% |
Adaptimmune Therapeutics PLC | -15.00% |
Akari Therapeutics PLC | -62.22% |
Biodexa Pharmaceuticals Plc | -93.25% |
NuCana PLC | -78.47% |